That decision is left to the shareholders to vote. As far as Dean not answering the overhead expense question - we don't know if the question was posed correctly or not. I agree that he is at the biggest hurdle in his career and all the longs are right there with him. Its like asking the groom the night of his wedding what he ate for dinner last night. Give things a chance we are waiting for the FDA. That is the only focus if you believe in Dean and his creation. See you in the circle.
News 
Market Data 
Discover 
AI
